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RESULTS

OBJECTIVES
• To define the mutant p53-regulated transcriptome of lung
cancer cells with alterations at V157 and R158 in the p53
tumor suppressor.

A.

DISCUSSION
B.

• To determine the biological effects of lung-enriched p53
mutations in lung cancer cells.
BACKGROUND
• Missense mutations in the tumor suppressor gene TP53 occur in 54% of lung
adenocarcinomas and 86% of squamous cell lung cancers. The most
common mutations in p53 render the protein not only unable to perform its
tumor suppressive function but frequently also lead to a gain of oncogenic
function (GOF).
• We and others have shown that lung tumors are enriched for missense
mutations in p53 at codons 157 and 158, a distinct lung “cluster.”
• The gene PLAU encodes urokinase-type plasminogen activator (uPA), a key
regulator of extracellular matrix cleavage via the plasminogen activation
system. uPA is highly expressed in several solid tumor types and is
associated with poor clinical prognosis.
• We hypothesize that p53 mutations at V157 and R158 directly regulate gain
of oncogenic function through changes in target gene expression, specifically
in lung cancer.

Figure 2. Expression of uPA
(PLAU) is p53-dependent in the
human lung cancer cell line
H2087 (V157F mutant p53).
Western blotting (Panel A) and
qRT-PCR
(Panel
B)
were
performed to confirm protein
products and mRNA expression of
the PLAU gene, identified by RNAsequencing.

Figure 1. Transcriptomic analysis reveals distinct
p53-regulated genes. RNA-sequencing was performed
to identify differentially expressed genes between siCtrland sip53-transfected cells harboring the p53 mutations
V157F (H2087), R158L (H441), and R158P (H2110).
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• RNA-sequencing was carried out by the Wistar Institute Genomics and Bioinformatics
Core Facilities. Cell sequencing reads were aligned to human genome hg19 using
Bowtie2, and differentially expressed genes were identified using DESeq2 method.
Enrichment analysis was performed using Ingenuity Pathway Analysis.
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• qRT-PCR was performed for selected genes using the Step One Plus Real Time-PCR
System with Fast SYBR Green Master Mix, with gene values normalized to GAPDH.
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• Western blotting was performed to detect protein expression using antibodies against
p53 (DO-1) and uPA.
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METHODS
• The human lung cancer cell lines A549 (wt p53), H2087 (V157F mut p53), H441
(R158L mut p53), and H2110 (R158P mut p53) were obtained from ATCC and were
cultured in standard tissue culture conditions. To determine the effects of transient p53
knockdown, cells were transfected with 25nM siCtrl (scramble siRNA) or sip53. At 72
hours post-transfection, cells were lysed to harvest protein and conditioned medium
was harvested for secreted proteins. RNA was isolated using RNeasy kit.

• Cell migration was measured through a standard wound healing assay. A549 and
H2087 cells were seeded in 24-well plates at 150,000 cells/well and 200,000 cells/well,
respectively, and were fully confluent at 48 hours when a scratch was made. Images
were taken at regular intervals and scratch diameter was calculated as percentage of
100% scratch closure.

• With p53 depletion, protein (Figure 2A) and mRNA (Figure 2B)
expression of the uPA pro-enzyme pro-uPA and its activated Band A-chains increased in the V157F mutant p53 lung cancer cell
line H2087. Secreted uPA also increased as measured in
conditioned media from H2087 cells (Figure 2A).
• Cell migration is increased by V157F mutant p53-depleted
H2087 cells compared with mutant p53-expressing H2087 cells,
while A549 cells (wt p53) showed no p53-dependent difference in
migration rate (Figure 3).
CONCLUSIONS
• To our knowledge, GOF phenotypes in lung cancer cells
harboring V157F mutp53 have not been characterized.

Table 1. Biological functions significantly altered by mutant p53 depletion
in H2087, H441, and H2110 cells.
Function

• V157F, R158L, and R158P mutant p53 regulate distinct groups of
genes (Figure 1) with common biological functions (Table 1) in
lung cancer cells harboring these lung-enriched mutations.
Notably, mutant p53 represses genes associated with functions
including cell viability, migration, and invasion.

• We have shown here that mutp53 represses uPA expression
in human lung cancer cells with endogenous V157F
mutp53, and depletion of p53 in these cells leads to an
increase in migration.
• These findings prompt a re-examination of the signaling
pathways associated with uPA. Further study is needed to
elucidate the mechanism of the p53-dependent alterations
in uPA expression and to establish additional biological
effects of V157F mutp53.
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Figure 3. H2087 cells depleted of V157F mutant p53 exhibit increased cell migration. In
a real time scratch assay, cell migration was increased in sip53-transfected H2087 cells.

ACKNOWLEDGEMENT
Funding source: RO1 CA164834 (SM)

